Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan for refractory hypertension in peritoneal dialysis patients
ChiCTR2100043544Phase 4Recruiting
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sacubitril + valsartan in hypertension (HTN), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: 24-hour ambulatory blood pressure. Started Mar 2021; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2100043544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043544.